UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical Cancer Research, ISSN 1078-0432, 02/2003, Volume 9, Issue 2, pp. 606 - 612
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Breast Neoplasms - immunology | Humans | Lung Neoplasms - pathology | Reference Values | Stomach Neoplasms - pathology | Neoplasms - blood | Killer Cells, Natural - immunology | Female | Colorectal Neoplasms - blood | Genital Neoplasms, Female - blood | Genital Neoplasms, Female - immunology | Stomach Neoplasms - immunology | Antigens, CD - blood | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Stomach Neoplasms - blood | Breast Neoplasms - pathology | Neoplasms - immunology | Breast Neoplasms - blood | Lymphocyte Count | T-Lymphocytes - immunology | Lung Neoplasms - blood | Colorectal Neoplasms - pathology | Neoplasm Staging | Neoplasms - pathology | Genital Neoplasms, Female - pathology | Cytotoxicity, Immunologic | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 08/2017, Volume 127, Issue 8, pp. 2930 - 2940
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunohistochemistry | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Gene Expression Regulation, Neoplastic | Tumor Microenvironment | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Interferon-gamma - metabolism | Immune System | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Signal Transduction | Skin Neoplasms - immunology | Carcinoma - immunology | Programmed Cell Death 1 Receptor - metabolism | Treatment Outcome | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Carcinoma, Non-Small-Cell Lung - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Pilot Projects | Sequence Analysis, RNA | Biopsy | Melanoma - immunology | Melanoma - drug therapy | ROC Curve | Carcinoma, Non-Small-Cell Lung - drug therapy | PD-1 protein | Lung cancer | Clinical trials | Cytotoxicity | Biology | Lymphocytes T | Cancer therapies | Metastases | Lymphocytes | Adaptation | Antigen presentation | Squamous cell carcinoma | Cytokines | Melanoma | Inflammation | Gene expression | Immune checkpoint | PD-L1 protein | Head and neck cancer | Antitumor activity | Ligands | Interferon | Chemokines | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1039 - 1046
topoisomerase I inhibitor | T‐DM | HER2 | bystander killing | Antibody‐drug conjugate | T-DM | Antibody-drug conjugate | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptor, ErbB-2 - genetics | Breast Neoplasms - immunology | Humans | Ado-Trastuzumab Emtansine | Stomach Neoplasms - pathology | Maytansine - pharmacology | Immunoconjugates - immunology | Breast Neoplasms - enzymology | Immunoconjugates - pharmacology | Topoisomerase I Inhibitors - pharmacology | Neoplasms - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Camptothecin - immunology | Receptor, ErbB-2 - immunology | Camptothecin - analogs & derivatives | Stomach Neoplasms - enzymology | Stomach Neoplasms - genetics | Maytansine - analogs & derivatives | Neoplasms - enzymology | Stomach Neoplasms - immunology | Animals | Breast Neoplasms - genetics | Bystander Effect - drug effects | Breast Neoplasms - pathology | Mice, Nude | Neoplasms - immunology | Cell Membrane Permeability - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal, Humanized - immunology | Neoplasms - pathology | Camptothecin - pharmacology | Maytansine - immunology | Trastuzumab | Viral antibodies | Epidermal growth factor | Imaging systems | Antibodies | Permeability | Drug therapy | Biopharmaceutics | Tumors | Antigens | Hematology | Laboratories | Toxicity | DNA topoisomerase | Polymerization | Clinical trials | Cytotoxicity | Breast cancer | ErbB-2 protein | Stomach cancer | Lymphoma | Hypotheses | Antitumor agents | Xenografts | Antitumor activity | Drug dosages | Payloads | Index Medicus | Original
Journal Article
Clinical immunology (Orlando, Fla.), ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | Life Sciences & Biomedicine | Immunology | Science & Technology | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors | Index Medicus
Journal Article
Asian Pacific journal of cancer prevention : APJCP, ISSN 1513-7368, 2014, Volume 15, Issue 2, pp. 945 - 950
Overall survival | Gastric cancer | Systemic inflammation | Glasgow prognostic score (GPS) | Life Sciences & Biomedicine | Oncology | Science & Technology | Inflammation - pathology | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Male | Stomach Neoplasms - pathology | Liver Neoplasms - mortality | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Inflammation - drug therapy | Inflammation Mediators - metabolism | Female | Liver Neoplasms - secondary | Inflammation - mortality | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Inflammation - immunology | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2017, Volume 20, Issue 1, pp. 156 - 163
Chemotherapy | Prognosis | Medicine & Public Health | Mismatch repair | Gastroenterology | Abdominal Surgery | Oncology | Cancer Research | Microsatellite instability | Surgical Oncology | Gastric cancer | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Microsatellite Instability | Follow-Up Studies | Humans | Male | Stomach Neoplasms - pathology | DNA Mismatch Repair - genetics | Cisplatin - administration & dosage | Organoplatinum Compounds - administration & dosage | Peritoneal Neoplasms - drug therapy | Fluorouracil - administration & dosage | Lung Neoplasms - secondary | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Peritoneal Neoplasms - immunology | Neutrophils - pathology | Peritoneal Neoplasms - secondary | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Liver Neoplasms - genetics | Biomarkers, Tumor - analysis | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Survival Rate | Combined Modality Therapy | Stomach Neoplasms - drug therapy | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Lymphocytes - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Cancer patients | Care and treatment | Immune response | Patient outcomes | Immunotherapy | Metastasis | Stomach cancer | Cancer | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 10/2011, Volume 60, Issue 10, pp. 1419 - 1430
Immunology | Medicine & Public Health | Cytokine | Interleukin-13 | Prognostic factor | Oncology | Cancer Research | Arginase | Myeloid-derived suppressor cell | Cancer | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Esophagus | Tumors | Pancreatic Neoplasms - blood | Prognosis | Enzyme-Linked Immunosorbent Assay | Cell Separation | Esophageal Neoplasms - blood | Humans | Kaplan-Meier Estimate | Proportional Hazards Models | Interleukin-13 - immunology | Immunophenotyping | Male | Th2 Cells - immunology | Esophageal Neoplasms - immunology | Stomach Neoplasms - immunology | Flow Cytometry | Stomach Neoplasms - blood | Myeloid Cells - immunology | Pancreatic Neoplasms - immunology | Esophageal Neoplasms - mortality | Female | Pancreatic Neoplasms - mortality | Stomach Neoplasms - mortality | Interleukin-13 - blood | Medical colleges | Care and treatment | Interleukins | Analysis | Oncology, Experimental | Research | Vascular endothelial growth factor | Stomach cancer | Esophageal cancer | Enzyme-linked immunosorbent assay | Index Medicus | Original
Journal Article
International journal of cancer, ISSN 0020-7136, 06/2006, Volume 118, Issue 12, pp. 3124 - 3132
epidemiology | allergy | neoplasms | etiology | Allergy | Etiology | Epidemiology | Neoplasms | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunopathology | General aspects | Biological and medical sciences | Allergic diseases | Medical sciences | Tumors | Humans | Glioma - immunology | Hypersensitivity - immunology | Genital Neoplasms, Female - immunology | Esophageal Neoplasms - immunology | Case-Control Studies | Stomach Neoplasms - immunology | Lung Neoplasms - immunology | Brain Neoplasms - immunology | Colorectal Neoplasms - immunology | Confounding Factors (Epidemiology) | Neoplasms - immunology | Thyroid Neoplasms - immunology | Pancreatic Neoplasms - immunology | Urinary Bladder Neoplasms - immunology | Female | Hypersensitivity - epidemiology | Hematologic Neoplasms - immunology | Research Design | Neoplasms - epidemiology | Index Medicus
Journal Article